Cargando…
Pharmacokinetics of Drugs in Cachectic Patients: A Systematic Review
Cachexia is a weight-loss process caused by an underlying chronic disease such as cancer, chronic heart failure, chronic obstructive pulmonary disease, or rheumatoid arthritis. It leads to changes in body structure and function that may influence the pharmacokinetics of drugs. Changes in gut functio...
Autores principales: | Trobec, Katja, Kerec Kos, Mojca, von Haehling, Stephan, Springer, Jochen, Anker, Stefan D., Lainscak, Mitja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835942/ https://www.ncbi.nlm.nih.gov/pubmed/24282510 http://dx.doi.org/10.1371/journal.pone.0079603 |
Ejemplares similares
-
Iohexol clearance is superior to creatinine-based renal function estimating equations in detecting short-term renal function decline in chronic heart failure
por: Cvan Trobec, Katja, et al.
Publicado: (2015) -
Influence of cancer cachexia on drug liver metabolism and renal elimination in rats
por: Cvan Trobec, Katja, et al.
Publicado: (2015) -
Growth hormone, insulin-like growth factor 1, and insulin signaling—a pharmacological target in body wasting and cachexia
por: Trobec, Katja, et al.
Publicado: (2011) -
Potential drug-drug interactions in hospitalized patients with chronic heart failure and chronic obstructive pulmonary disease
por: Roblek, Tina, et al.
Publicado: (2014) -
The obesity paradox in chronic disease: facts and numbers
por: Lainscak, Mitja, et al.
Publicado: (2012)